331 related articles for article (PubMed ID: 27177280)
21. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
[TBL] [Abstract][Full Text] [Related]
22. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.
Huang CY; Chen CA; Chen YL; Chiang CJ; Hsu TH; Lin MC; Lai MS; Chen CJ; You SL; Cheng WF
PLoS One; 2012; 7(12):e51372. PubMed ID: 23251510
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
24. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus.
Schwartz SM; Weiss NS; Daling JR; Gammon MD; Liff JM; Watt J; Lynch CF; Newcomb PA; Armstrong BK; Thompson WD
Cancer; 1996 Feb; 77(4):717-24. PubMed ID: 8616764
[TBL] [Abstract][Full Text] [Related]
25. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage.
Madison T; Schottenfeld D; Baker V
Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
27. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
[TBL] [Abstract][Full Text] [Related]
28. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
Clayton Smith D; Kenneth Macdonald O; Gaffney DK
Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
Parker WH; Fu YS; Berek JS
Obstet Gynecol; 1994 Mar; 83(3):414-8. PubMed ID: 8127535
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome and natural history of uterine adenosarcomas.
Arend R; Bagaria M; Lewin SN; Sun X; Deutsch I; Burke WM; Herzog TJ; Wright JD
Gynecol Oncol; 2010 Nov; 119(2):305-8. PubMed ID: 20688363
[TBL] [Abstract][Full Text] [Related]
31. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
32. Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions.
Ng VY; Scharschmidt TJ; Mayerson JL; Fisher JL
Anticancer Res; 2013 Jun; 33(6):2597-604. PubMed ID: 23749914
[TBL] [Abstract][Full Text] [Related]
33. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
[TBL] [Abstract][Full Text] [Related]
34. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
[TBL] [Abstract][Full Text] [Related]
35. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
37. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract][Full Text] [Related]
38. [Uterine sarcoma. Clinico-statistical study over 5 years (1963-1967)].
Cargnello U
Friuli Med; 1968; 23(6):997-1017. PubMed ID: 5738506
[No Abstract] [Full Text] [Related]
39. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases.
Rouhani P; Fletcher CD; Devesa SS; Toro JR
Cancer; 2008 Aug; 113(3):616-27. PubMed ID: 18618615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
